Back

Cusp-overlap technique to reduce permanent pacemaker implantation rate after transcatheter aortic valve implantation

1 September 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: TAVI and beyond Intervention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Miguel Abrantes De Figueiredo

Centro Hospitalar Universitario de Lisboa Central, E.P.E., Lisboa (Portugal)

8 More presentations in this session

Presentation thumbnail
Prospective evaluation of transcatheter aortic valve implantation (TAVI) with coronary alignment and impact on coronary access
Doctor C. pavitt (Brighton, GB)
Abstract Slides Video
Presentation thumbnail
Implementing a novel selection criteria and pathway for same-day discharge after TAVI
Doctor R. Sethi (Uxbridge, GB)
Abstract Slides Video
Presentation thumbnail
Permanent pacemaker implantation is associated with an increased risk of heart failure hospitalization in transcatheter aortic valve implantation patients with reduced systolic function
Doctor K. Hu (Wuerzburg, DE)
Abstract Slides Video
Presentation thumbnail
Correlation of prosthesis position on mid-term pacing burden in patients with new permanent pacemaker after TAVI
Doctor P. Breitbart (Frankfurt am Main, DE)
Abstract Slides Video
Presentation thumbnail
Comparison of mortality scores performance in transcatheter aortic valve replacement: suiting up to percutaneous intervention.
Doctor A. Martins (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
TAVI and beyond

The Event

Event poster

ESC Congress 2024

1 September 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Contemporary implantation protocols enable markedly lower pacemaker rate for selfexpandable TAVR
thumbnail
Congress Presentation
Prevalence and predictors of pacemaker implantation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: TAVI-NOR study
thumbnail
Congress Presentation
Probability of requiring permanent cardiac pacing after transcatheter aortic valve implantation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources